Medicinal Genomics
Medicinal Genomics is a Woburn, MA-based molecular diagnostics company that develops AOAC-certified qPCR assays, DNA extraction kits, instruments, and genomic services for microbial and pathogen testing of cannabis, hemp, supplement, and natural-product manufacturers, labs, and cultivators.
- Company typePrivate
- Founded2011
- HeadquartersAmsterdam, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medicinal Genomics does
Medicinal Genomics Corps is a Woburn, Massachusetts-based molecular diagnostics company founded by Kevin McKernan, formerly a research director on the Human Genome Project at MIT and the first to sequence the cannabis genome. The company develops and commercializes qPCR-based testing assays, DNA extraction kits, instrumentation, and genomic services targeting microbial safety, plant pathogen detection, sex determination, and genotyping for cannabis, hemp, supplement, and natural-product matrices. Core offerings include the PathoSEEK multiplex qPCR assay family (Salmonella, STEC, E. coli, Listeria, Aspergillus, Total Yeast and Mold, Total Aerobic Count), MaGiC Lysis sample-prep kits, the BMS Mic qPCR Cycler and Myra Liquid Handler (sold under a November 2023 partnership with Bio Molecular Systems), StrainSEEK whole-genome sequencing, CannSNP90 genotyping, FemINDICAtor plant sex detection, PsiloSEEK mushroom speciation, and the Grim Reefer free-DNA removal kit. Multiple PathoSEEK assays hold AOAC Performance Tested Methods certifications on cannabis and supplement matrices, and the company manufactures under ISO 13485 quality systems.
Medicinal Genomics firmographics
Firmographics- Name
- Medicinal Genomics
- Legal name
- Medicinal Genomics Corps
- Website
- https://medicinalgenomics.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medicinal Genomics is a Woburn, MA-based molecular diagnostics company that develops AOAC-certified qPCR assays, DNA extraction kits, instruments, and genomic services for microbial and pathogen testing of cannabis, hemp, supplement, and natural-product manufacturers, labs, and cultivators.
- Ownership category
- akta.pro rank
Medicinal Genomics industry classification
Industry- Product category
- Molecular Diagnostics and Cannabis Testing Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where Medicinal Genomics is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Medicinal Genomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- qPCR Detection Assays and Kits: Medicinal Genomics generates revenue primarily through sale of qPCR detection assay kits, DNA extraction reagents, and multiplex testing panels. These consumable products are sold in kits that include all necessary reagents for specific microbial targets. Customers include testing labs, manufacturers, and cultivators who purchase recurring consumable supplies.
- Instruments and Equipment: Sale of Mic qPCR Cycler and Myra Liquid Handler instruments. These represent capital equipment purchases for labs implementing the testing platform.
- Genomic Services: Fee-for-service genomic sequencing and analysis including StrainSEEK whole genome sequencing, CannSNP90 genotyping, and PathoSEEK ID microbial speciation services.
- Automation Solutions: Turnkey automation solutions integrating with third-party liquid handling systems from Agilent, Hamilton Robotics, and MGI/BGI for high-throughput laboratory operations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PathoSEEK ID microbial speciation service |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Medicinal Genomics product offering
Product offeringCore offering
Medicinal Genomics designs, manufactures, and sells qPCR-based molecular testing kits, reagents, and instruments for the cannabis, hemp, supplement, and natural products industries. Its product line includes PathoSEEK microbial detection assays, MaGiC Lysis Kits, the BMS Mic qPCR Cycler and BMS Myra Liquid Handler, plus genomic services such as StrainSEEK strain identification and CannSNP90 authentication. The company serves regulated cannabis testing laboratories, cultivators, and supplement/food manufacturers in more than 15 countries.
Product overview
Medicinal Genomics offers a comprehensive qPCR-based molecular testing platform for cannabis, hemp, and natural products. The core PathoSEEK qPCR Detection Assays platform is supported by MaGiC Lysis and SenSATIVAx DNA extraction kits, BMS Mic qPCR Cycler and Myra Liquid Handler instrumentation, and genomic services including StrainSEEK sequencing and PathoSEEK ID microbial speciation. Additional offerings include FemINDICAtor plant sex detection, PsiloSEEK mushroom speciation, plant pathogen assays, and the Grim Reefer Free DNA Removal Kit. The company also provides automation solutions integrating with Agilent, Bio-Rad, Hamilton Robotics, and MGI/BGI platforms.
Differentiator
Problem solved
Functional benefit
Brands
- PathoSEEK: qPCR Detection Assays platform for microbial testing
- MaGiC Lysis
- StrainSEEK
- CannSNP90
- FemINDICAtor
- PsiloSEEK
- CannMed
- Grim Reefer
- SenSATIVAx
Products and services
- PathoSEEK qPCR Detection Assays Validated qPCR-based detection assays for microbial and pathogen contamination testing in cannabis and hemp flower and products, used by regulated testing laboratories and cultivators for release testing.
- MaGiC Lysis Kits Sample preparation kits designed to extract DNA from cannabis and hemp matrices for downstream qPCR detection on the PathoSEEK platform, used by testing laboratories.
- BMS Mic qPCR Cycler Compact benchtop qPCR thermal cycler instrument purpose-built for cannabis and supplement testing laboratories running the PathoSEEK qPCR assay workflow.
- BMS Myra Liquid Handler Automated liquid handling instrument that prepares qPCR reaction plates for high-throughput cannabis and supplement testing laboratories.
- StrainSEEK Genomic sequencing service that identifies and authenticates cannabis and hemp strains, providing genetic verification for cultivators, dispensaries, and testing laboratories.
- CannSNP90 SNP-based genotyping panel and service for cannabis genetic verification, used by cultivators and breeders to confirm cultivar identity and genetic relationships.
- FemINDICAtor qPCR assay for early plant sex identification in cannabis and hemp, used by cultivators to separate male plants from female plants early in the growth cycle.
- PsiloSEEK qPCR detection assay for identifying and authenticating psilocybin mushroom species and products, used by mycology testing laboratories and supplier/manufacturers.
- Grim Reefer qPCR detection assay for cannabis-specific pathogens, used to screen flower and products for microbial contamination in regulated testing workflows.
Quantifiable outcome
- Reduce hold and release times from a week to a day
- +7 more outcomes
Companies that use Medicinal Genomics
Customer profileNamed customers22 records
Segments4 records
Ideal customer profiles3 records
Medicinal Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
Feature10 records
Medicinal Genomics partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core.
- Bio Molecular Systems (BMS)corePartnership agreement giving Medicinal Genomics rights to market BMS's qPCR Mic instrument and Myra Liquid Handler. This partnership provides an integrated testing platform combining BMS's instrument hardware with MGC's PathoSEEK assays and protocols, creating a turnkey solution for cannabis and hemp microbial testing.
- Analogic SolutionscoreAuthorized distributor for Medicinal Genomics products covering Caribbean region including Trinidad and Tobago, Guyana, French Guyana, and Suriname.
- Analytical Technologies S.A.coreAuthorized distributor covering Central America and South America region including Argentina and surrounding countries.
- Gentech BioSciencescoreAuthorized distributor for Colombia covering that market with local sales and support capabilities.
- Green GeneticscoreAuthorized distributor for Puerto Rico providing local access to Medicinal Genomics testing products.
- SanitascoreAuthorized distributor for Colombia covering that market with local sales and support capabilities.
- TagacacoreAuthorized distributor for Uruguay providing local access to Medicinal Genomics products.
- AlphachromcoreAuthorized distributor covering Croatia, Bosnia and Herzegovina, Kosovo, and Slovenia in Eastern Europe.
- CannabreezecoreAuthorized distributor covering Greece and Malta, providing Mediterranean region coverage.
- DiagnostechcoreAuthorized distributor for South Africa providing African market access.
- Eldan Electronic Instruments Ltd.coreAuthorized distributor covering Israel and Palestine for Medicinal Genomics products.
- Life BiomedicalscoreAuthorized distributor for Northern Macedonia covering that market.
- Paralab SAcoreAuthorized distributor covering Czechia, Germany, Netherlands, and Spain. New distributor partnership.
- SoquimicacoreAuthorized distributor for Portugal providing Iberian Peninsula coverage.
- Genomax TechnologiescoreAuthorized distributor covering Thailand, Singapore, and Malaysia for Southeast Asian market access.
- Agilent TechnologiescoreTurnkey automation solutions provider for high-throughput laboratory operations using Agilent liquid handling systems integrated with Medicinal Genomics PathoSEEK assays.
- Hamilton RoboticscoreTurnkey automation solutions provider for laboratory automation integration with Medicinal Genomics testing platform.
- MGI/BGIcoreTurnkey automation solutions provider for high-throughput sequencing and laboratory automation integration.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Medicinal Genomics competitors and assessment
Company assessmentBroad incumbents
- Agilent Technologies: Manufacturer of the AriaMx Real-Time PCR System, explicitly validated for PathoSEEK assays, and a turnkey automation partner for MGC's high-throughput solutions. Agilent's broader analytical-instrument portfolio and large installed base position it as both a channel partner and a potential competing reagent supplier.
- Eurofins Scientific: World's largest food and environmental testing services company operating hundreds of laboratories. Competes with MGC on the testing-services side (PathoSEEK ID, StrainSEEK) and is a potential partner for high-throughput cannabis sample speciation work.
- QIAGEN: Global molecular diagnostics and sample-preparation company with qPCR reagent portfolios across food, pharma, and human diagnostics. Comparable reagent/customer base and shared molecular-testing technology stack make QIAGEN a natural competitor as cannabis testing scales.
- Neogen Corporation: Food and animal safety testing company formed via the 3M Food Safety merger, with molecular pathogen detection capabilities. Directly competes for the supplement/nutraceutical testing customers MGC is targeting as an adjacent market.
- Thermo Fisher Scientific: QuantStudio qPCR instruments are validated for PathoSEEK assays per MGC documentation. As the largest life-science tools company, Thermo Fisher could readily launch its own cannabis/hemp-validated kits and reagents, posing a structural threat to MGC's reagent business.
- Bio-Rad Laboratories: Major manufacturer of qPCR instruments (notably the CFX96 Touch) that are explicitly validated for use with Medicinal Genomics' PathoSEEK assays. Bio-Rad is a broad life-science incumbent with the R&D and distribution scale to expand into cannabis-specific qPCR kits, making it the most direct platform competitor.
- Bio-Techne: Life-science reagents and diagnostics company with qPCR and genomic product lines. Comparable technology platform and reagent-sales model, particularly in the molecular research and diagnostics segments MGC serves.
- bioMérieux: Leading food and clinical pathogen-testing company with established molecular (PCR-based) product lines. As MGC expands from cannabis into supplements and natural products, bioMérieux is the dominant incumbent it must displace, with much larger sales coverage and brand recognition.
- Charles River Laboratories: Major contract research and laboratory services company with microbial and molecular testing capabilities serving biopharma and food safety. Comparable end-customer profile and service-revenue model relevant to MGC's genomic services and PathoSEEK ID offerings.
Direct peers
- Hygiena: Specializes in PCR-based food and environmental pathogen detection kits and instruments sold to testing labs and food manufacturers. Closely comparable technology stack and customer type (labs needing validated microbial detection), though focused on food/environmental rather than cannabis/hemp matrices.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Medicinal Genomics social profiles
Digital presenceMedicinal Genomics compliance and trust
Trust signalCompliance7 records
Medicinal Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medicinal Genomics leadership team
Management profileNumber of profiles
Profiles4 records
Medicinal Genomics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medicinal Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medicinal Genomics
What does Medicinal Genomics do?
Medicinal Genomics designs, manufactures, and sells qPCR-based molecular testing kits, reagents, and instruments for the cannabis, hemp, supplement, and natural products industries. Its product line includes PathoSEEK microbial detection assays, MaGiC Lysis Kits, the BMS Mic qPCR Cycler and BMS Myra Liquid Handler, plus genomic services such as StrainSEEK strain identification and CannSNP90 authentication. The company serves regulated cannabis testing laboratories, cultivators, and supplement/food manufacturers in more than 15 countries.
Is Medicinal Genomics a public or private company?
Medicinal Genomics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medicinal Genomics founded?
Medicinal Genomics was founded in 2011. It employs 11 to 50 people.
Where is Medicinal Genomics based?
Medicinal Genomics is headquartered in Amsterdam, Netherlands, in the Europe region.
How does Medicinal Genomics make money?
Four revenue lines are on record. qPCR Detection Assays and Kits are the primary driver. The others are instruments and Equipment, genomic Services and automation Solutions.
Who are Medicinal Genomics's main competitors?
Broad incumbents on record are Agilent Technologies, Eurofins Scientific, QIAGEN, Neogen Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Bio-Techne, bioMérieux and Charles River Laboratories. Hygiena is listed as a direct peer.
Does Medicinal Genomics have an API?
No public API is recorded for Medicinal Genomics.
What industry is Medicinal Genomics in?
Medicinal Genomics's product category is Molecular Diagnostics and Cannabis Testing Reagents. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 325413 and its SIC code is 2835.